Europe Antibody Discovery Market Forecast to 2030 - Regional Analysis - by Antibody Type, Nature, Services, and End User

Description

List of Tables

The Europe antibody discovery market was valued at US$ 8,24,441.11 million in 2022 and is expected to reach US$ 13,29,481.60 million by 2030; it is estimated to register a CAGR of 6.2% from 2022 to 2030.

Rising Incidence of Cancer Drives Europe Antibody Discovery Market

As per the Global Cancer Observatory (GLOBOCAN) estimates published in 2020, there were 19.3 million cancer cases across the world. By January 2030, the population of cancer survivors is estimated to reach 22.1 million, which can be primarily associated with the aging of the population. Lung, breast, colorectal, prostate, and breast are among the most commonly reported cancer types. The rising incidences of cancer have raised concerns worldwide.

Cancer is now a lifestyle disease commonly seen among people with unhealthy eating habits and those who don't engage much in physical activities. The frequent consumption of alcohol and tobacco adds up to the risk of developing cancer. Chronic infectious diseases in low- and middle-income countries can further aggravate the cancer risk factors. An upsurge in the incidence of cancer indicates the need for innovative cancer treatments. Monoclonal antibodies represent a promising class of targeted anticancer agents that enhance the natural ability of immune systems to suppress cancer cell activity and eliminate cancer cells. Antibody-drug conjugates (ADCs) have also shown promising results in cancer treatment. Further, progress in modern biotechnology allows researchers and companies to provide well-designed novel antibodies, paving the way for successful treatments of various types of cancer. Thus, the burgeoning incidence of different types of cancer boosts the antibody discovery market growth.

Europe Antibody Discovery Market Overview

The European antibody discovery market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant share of the global market. It is expected to register a robust growth rate in the coming years owing to the surging use of monoclonal antibodies in R&D applications, cancer therapies, and immunological disorder management. Further, the rising need for patient data management systems, the prevalence of chronic diseases, and government initiatives for the implementation of antibody services are expected to provide growth opportunities for the antibody discovery market in countries such as France, Italy, and Spain.

Europe Antibody Discovery Market Revenue and Forecast to 2030 (US$ Billion)

Europe Antibody Discovery Market Segmentation

The Europe antibody discovery market is categorized into antibody type, nature, services, end user, and country.

Based on antibody type, the Europe antibody discovery market is segmented into monoclonal antibodies, polyclonal antibodies, and others. The monoclonal antibodies segment held the largest Europe antibody discovery market share in 2022.

In terms of nature, the Europe antibody discovery market is segmented into human and humanized, chimeric, and murine. The human and humanized segment held the largest Europe antibody discovery market share in 2022.

By services, the Europe antibody discovery market is divided into phage display, hybridoma, transgenic animal, single cell, and yeast display. The phage display segment held the largest Europe antibody discovery market share in 2022.

Based on end user, the Europe antibody discovery market is categorized into pharmaceutical and biotechnology companies, research laboratories, and others. The pharmaceutical and biotechnology companies segment held the largest Europe antibody discovery market share in 2022.

Based on country, the Europe antibody discovery market is categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe antibody discovery market share in 2022.

Charles River Laboratories International Inc, Creative Biolabs Inc, Evotec SE, Sartorius AG, Aragen Life Sciences Ltd, Twist Bioscience Corp, and Biocytogen Pharmaceuticals Beijing Co Ltd. are some of the leading companies operating in the Europe antibody discovery market.

Product Code: BMIRE00030736

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Antibody Discovery Market - Key Market Dynamics

4.1 Market Drivers
- 4.1.1 Increasing Investments in Research & Development
- 4.1.2 Rising Incidence of Cancer
4.2 Market Restraints
- 4.2.1 High Cost of Production
4.3 Market Opportunities
- 4.3.1 Proliferation of Biotechnology Industry in Developing Regions
4.4 Future Trends
- 4.4.1 Developments for Custom Antibodies
4.5 Impact of Drivers and Restraints:

5. Antibody Discovery Market - Europe Market Analysis

5.1 Europe Antibody Discovery Market Revenue (US$ Million), 2020-2030

6. Europe Antibody Discovery Market Analysis - by Antibody Type

6.1 Overview
6.2 Monoclonal Antibodies
- 6.2.1 Overview
- 6.2.2 Monoclonal Antibodies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Polyclonal Antibodies
- 6.3.1 Overview
- 6.3.2 Polyclonal Antibodies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Others
- 6.4.1 Overview
- 6.4.2 Others: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Antibody Discovery Market Analysis - by Nature

7.1 Overview
7.2 Human and Humanized
- 7.2.1 Overview
- 7.2.2 Human and Humanized: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Chimeric
- 7.3.1 Overview
- 7.3.2 Chimeric: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Murine
- 7.4.1 Overview
- 7.4.2 Murine: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Antibody Discovery Market Analysis - by Services

8.1 Overview
8.2 Phage Display
- 8.2.1 Overview
- 8.2.2 Phage Display: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Hybridoma
- 8.3.1 Overview
- 8.3.2 Hybridoma: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Transgenic Animal
- 8.4.1 Overview
- 8.4.2 Transgenic Animal: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Yeast Display
- 8.5.1 Overview
- 8.5.2 Yeast Display: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Single Cell
- 8.6.1 Overview
- 8.6.2 Single Cell: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Antibody Discovery Market Analysis - by End User

9.1 Overview
9.2 Pharmaceutical and Biotechnology Companies
- 9.2.1 Overview
- 9.2.2 Pharmaceutical and Biotechnology Companies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Research Laboratories
- 9.3.1 Overview
- 9.3.2 Research Laboratories: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Others
- 9.4.1 Overview
- 9.4.2 Others: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Antibody Discovery Market - Country Analysis

10.1 Europe Antibody Discovery Market, Revenue and Forecast to 2030
- 10.1.1 Europe: Antibody Discovery Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.1 UK
    - 10.1.1.1.1 Overview
    - 10.1.1.1.2 UK: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.1.3 UK: Antibody Discovery Market Breakdown, by Antibody Type
    - 10.1.1.1.4 UK: Antibody Discovery Market Breakdown, by Nature
    - 10.1.1.1.5 UK: Antibody Discovery Market Breakdown, by Services
    - 10.1.1.1.6 UK: Antibody Discovery Market Breakdown, by End User
  - 10.1.1.2 Germany
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 Germany: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.3 Germany: Antibody Discovery Market Breakdown, by Antibody Type
    - 10.1.1.2.4 Germany: Antibody Discovery Market Breakdown, by Nature
    - 10.1.1.2.5 Germany: Antibody Discovery Market Breakdown, by Services
    - 10.1.1.2.6 Germany: Antibody Discovery Market Breakdown, by End User
  - 10.1.1.3 France
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 France: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.3 France: Antibody Discovery Market Breakdown, by Antibody Type
    - 10.1.1.3.4 France: Antibody Discovery Market Breakdown, by Nature
    - 10.1.1.3.5 France: Antibody Discovery Market Breakdown, by Services
    - 10.1.1.3.6 France: Antibody Discovery Market Breakdown, by End User
  - 10.1.1.4 Italy
    - 10.1.1.4.1 Overview
    - 10.1.1.4.2 Italy: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.4.3 Italy: Antibody Discovery Market Breakdown, by Antibody Type
    - 10.1.1.4.4 Italy: Antibody Discovery Market Breakdown, by Nature
    - 10.1.1.4.5 Italy: Antibody Discovery Market Breakdown, by Services
    - 10.1.1.4.6 Italy: Antibody Discovery Market Breakdown, by End User
  - 10.1.1.5 Spain
    - 10.1.1.5.1 Overview
    - 10.1.1.5.2 Spain: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.5.3 Spain: Antibody Discovery Market Breakdown, by Antibody Type
    - 10.1.1.5.4 Spain: Antibody Discovery Market Breakdown, by Nature
    - 10.1.1.5.5 Spain: Antibody Discovery Market Breakdown, by Services
    - 10.1.1.5.6 Spain: Antibody Discovery Market Breakdown, by End User
  - 10.1.1.6 Rest of Europe
    - 10.1.1.6.1 Overview
    - 10.1.1.6.2 Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.6.3 Rest of Europe: Antibody Discovery Market Breakdown, by Antibody Type
    - 10.1.1.6.4 Rest of Europe: Antibody Discovery Market Breakdown, by Nature
    - 10.1.1.6.5 Rest of Europe: Antibody Discovery Market Breakdown, by Services
    - 10.1.1.6.6 Rest of Europe: Antibody Discovery Market Breakdown, by End User

11. Antibody Discovery Market-Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Antibody Discovery Market
11.3 Inorganic Growth Strategies
- 11.3.1 Overview
11.4 Organic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Charles River Laboratories International Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Creative Biolabs Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Evotec SE
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Sartorius AG
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Aragen Life Sciences Ltd
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Twist Bioscience Corp
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Biocytogen Pharmaceuticals Beijing Co Ltd
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms